3-methylquinoxaline-2-carboxylic acid: cytotoxic and genotoxic
ID Source | ID |
---|---|
PubMed CID | 6484678 |
SCHEMBL ID | 2056931 |
MeSH ID | M0585094 |
Synonym |
---|
BB 0252879 |
3-methyl-quinoxaline-2-carboxylic acid |
AKOS000558927 |
3-methylquinoxaline-2-carboxylic acid |
74003-63-7 |
FT-0672133 |
AG-0701 |
STL476641 |
SCHEMBL2056931 |
3-methyl-2-quinoxalinecarboxylic acid |
DTXSID10424475 |
2-quinoxalinecarboxylic acid, 3-methyl- |
mfcd03840415 |
J-512929 |
3-methyl-2-quinoxalinecarboxylic acid, vetranal(tm), analytical standard |
BCP25035 |
3-methyl-quinoxaline-2-carboxylic acid 100 microg/ml in acetonitrile |
mqca |
CS-W016815 |
C76365 |
A917111 |
HY-W016099 |
3-methylquinoxaline-2-carboxylicacid |
EN300-226768 |
PD088829 |
Z1198163353 |
Excerpt | Reference | Relevance |
---|---|---|
" The results indicate that 1,4-bisdesoxyquinocetone and MQCA are toxic to L-02 and Chang liver cells, and provide important new information towards understanding the olaquindox and quinocetone toxic mechanisms." | ( Cytotoxicity and genotoxicity of 1,4-bisdesoxyquinocetone, 3-methylquinoxaline-2-carboxylic acid (MQCA) in human hepatocytes. Ban, M; Fei, C; Wang, M; Wang, X; Xue, F; Zhang, K; Zhao, Z; Zheng, H, 2012) | 0.62 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (83.33) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.94) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |